How Epstein-Barr virus shapes immune responses in multiple sclerosis

FHS
June 10, 2024
2:36 am

Study found that EBV-specific immune responses in MS patients showed higher IgG titers and cell-mediated reactions to EBV antigens compared to healthy controls, suggesting a complex role of EBV in MS development.

CARGO Therapeutics heads to Nasdaq in first CAR-T cell therapy IPO pitch of 2023

A cancer cell therapy biotech that emerged just nine months ago with $200 million and a Phase I trial already underway will test the public

October 22, 2023

Second recipient of genetically modified pig heart dies, six weeks after surgery

Nearly six weeks after his surgery, the world’s second recipient of a genetically modified pig heart has died, the University of Maryland announced Tuesday. Lawrence

October 31, 2023

Cracking the Nutritional Puzzle: A Path Out Of Dallas’ Food Desert

Recently, I was shocked to hear that North Texas is one of the hardest-hit areas of the country for food insecurity. Shocked, but not surprised.

July 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.